Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 74Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Clinigen Group

02 2ORPHAN EUROPE SARL

03 1Recordati Rare Diseases

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Hemin

Brand Name : Normosang 25mg/ml (10 ml ampoules)

Dosage Form : INJ

Dosage Strength : 25mg/ml

Packaging : 4X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

hemin

Brand Name : Normosang

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 25 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Hemin

Brand Name : Normosang

Dosage Form : Hemin 250Mg 10Ml 4 Units Parenteral Use

Dosage Strength : 4 ampoules EV 250 mg 10 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

HEMIN

Brand Name : PANHEMATIN

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 268MG/VIAL

Packaging :

Approval Date :

Application Number : 2478765

Regulatory Info : Prescription

Registration Country : Canada

blank